D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$301M |
| 3 |
Bausch Health
BHC
|
+$273M |
| 4 |
SPDR Gold Trust
GLD
|
+$231M |
| 5 |
Amazon
AMZN
|
+$218M |
Top Sells
| 1 |
LyondellBasell Industries
LYB
|
+$414M |
| 2 |
AGN
ALLERGAN INC
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$349M |
| 4 |
IBM
IBM
|
+$254M |
| 5 |
Microsoft
MSFT
|
+$247M |
Sector Composition
| 1 | Energy | 12.35% |
| 2 | Consumer Discretionary | 12.14% |
| 3 | Technology | 11.81% |
| 4 | Healthcare | 10.57% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1726
DELISTED
Immunomedics Inc
IMMU
| $992K | ﹤0.01% |
258,978
+157,600
| +155% | +$604K |
|
1727
MSC Industrial Direct
MSM
$5.1B
| $991K | ﹤0.01% |
+13,719
| New | +$991K |
|
|
ZGNX
1728
DELISTED
Zogenix, Inc.
ZGNX
| $988K | ﹤0.01% |
90,152
-87,040
| -49% | -$954K |
|
|
ESRX
1729
DELISTED
Express Scripts Holding Company
ESRX
| $985K | ﹤0.01% |
11,355
-53,635
| -83% | -$4.65M |
|
|
ACTA
1730
DELISTED
Actua Corporation
ACTA
| $981K | ﹤0.01% |
63,311
+19,820
| +46% | +$307K |
|
1731
Kodak
KODK
$464M
| $980K | ﹤0.01% |
51,611
-15,003
| -23% | -$285K |
|
1732
Avient
AVNT
$3.34B
| $967K | ﹤0.01% |
25,886
-17,154
| -40% | -$641K |
|
1733
Century Aluminum
CENX
$2.09B
| $966K | ﹤0.01% |
+70,000
| New | +$966K |
|
|
FRSH
1734
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $964K | ﹤0.01% |
53,143
+5,903
| +12% | +$107K |
|
1735
California Water Service
CWT
$2.72B
| $963K | ﹤0.01% |
39,303
-14,813
| -27% | -$363K |
|
|
POZN
1736
DELISTED
POZEN INC
POZN
| $963K | ﹤0.01% |
124,793
+24,715
| +25% | +$191K |
|
1737
Acacia Research
ACTG
$304M
| $962K | ﹤0.01% |
89,827
+69,671
| +346% | +$746K |
|
1738
Select Medical
SEM
$1.54B
| $962K | ﹤0.01% |
120,365
-885,652
| -88% | -$7.08M |
|
1739
Acadia Pharmaceuticals
ACAD
$4.02B
| $960K | ﹤0.01% |
29,449
-144,752
| -83% | -$4.72M |
|
1740
Q2 Holdings
QTWO
$5.13B
| $959K | ﹤0.01% |
45,343
+15,814
| +54% | +$334K |
|
|
TCF
1741
DELISTED
TCF Financial Corporation Common Stock
TCF
| $957K | ﹤0.01% |
30,521
-17,351
| -36% | -$544K |
|
1742
New Mountain Finance
NMFC
$1.11B
| $956K | ﹤0.01% |
65,477
+45,611
| +230% | +$666K |
|
|
BT
1743
DELISTED
BT Group plc (ADR)
BT
| $954K | ﹤0.01% |
+29,292
| New | +$954K |
|
1744
LXP Industrial Trust
LXP
$2.67B
| $951K | ﹤0.01% |
+96,774
| New | +$951K |
|
1745
Travere Therapeutics
TVTX
$2.43B
| $951K | ﹤0.01% |
39,700
-5,900
| -13% | -$141K |
|
1746
Wayfair
W
$11.3B
| $951K | ﹤0.01% |
29,601
-19,729
| -40% | -$634K |
|
1747
TG Therapeutics
TGTX
$5.05B
| $950K | ﹤0.01% |
+61,346
| New | +$950K |
|
|
RGC
1748
DELISTED
Regal Entertainment Group
RGC
| $950K | ﹤0.01% |
41,605
-67,546
| -62% | -$1.54M |
|
|
HSNI
1749
DELISTED
HSN, Inc.
HSNI
| $950K | ﹤0.01% |
13,920
+1,779
| +15% | +$121K |
|
1750
Philips
PHG
$26.9B
| $946K | ﹤0.01% |
46,449
+2,806
| +6% | +$57.1K |
|